Patents
Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306)
05/2002
05/28/2002US6395474 Peptide nucleic acids
05/23/2002WO2001082971A3 Cyclodextrin containing glycopeptide antibiotic compositions
05/23/2002WO2001081373A3 Glycopeptide antibacterial compounds and methods of using same
05/22/2002EP0894093B1 Soluble tachykinin antagonists, the preparation and use thereof
05/21/2002US6392012 Glycopeptide derivatives and pharmaceutical compositions containing the same
05/21/2002US6391851 Hydrochlorides of vancomycin antibiotics and process for producing the same
05/16/2002WO2001081372A3 Vancomycin analogs
05/10/2002WO2002036612A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements
05/10/2002CA2426012A1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements
05/09/2002US20020055464 Polyacid glycopeptide derivatives
05/07/2002US6384211 Library of oligomeric carbopeptoid compounds for use in drug screening; oligomers have at least two carbohydrate amino acid subunits coupled together by an amide linkage
05/07/2002CA2190494C Heterodimer polypeptide immunogen carrier composition and method
05/02/2002EP1201676A2 PNA-DNA-PNA chimeric macromolecules
04/2002
04/30/2002CA2047997C Antibiotic, balhimycin, a process for its production and its use as pharmaceutical
04/24/2002EP1198256A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery
04/24/2002EP1137812A4 Dna-protein fusions and uses thereof
04/18/2002WO2002031155A2 Gene cluster for ramoplanin biosynthesis
04/18/2002US20020045574 Vancomycin analogs having improved activity against bacterial infection
04/17/2002CN1345333A Echinocandin/carbohydrate complexes
04/11/2002WO2001098328A3 Glycopeptide phosphonate derivatives
04/11/2002US20020042365 Vancomycin analogs
04/10/2002EP1194548A1 Novel pyrrhocoricin-derived peptides, and methods of use thereof
04/09/2002US6369193 Contulakin-G, analogs thereof and uses therefor
04/04/2002WO2002026776A2 Peptide-based compounds
04/04/2002WO2001098327A3 Glycopeptide carboxy-saccharide derivatives
03/2002
03/28/2002US20020038017 Synthesis of glycoconjugates of the lewis y epitope and uses thereof
03/26/2002US6361777 Method of coupling polysaccharides to proteins
03/21/2002WO2001079267A3 A glycopeptide and preparation thereof
03/21/2002US20020035063 Derivatives of laspartomycin and preparation and use thereof
03/19/2002US6359118 Carbohydrate crosslinked glycoprotein crystals
03/19/2002US6357163 Use of nucleic acid analogues in diagnostics and analytical procedures
03/14/2002WO2001079268A3 A glycopeptide and preparation thereof
03/14/2002WO2001002018A3 Compounds that associate on the intermolecular level and aggregate bodies that contain them
03/13/2002EP1185552A1 Retro-inverso peptides derived from interleukin-3
03/12/2002US6355611 Salt form of a conjugate useful in the treatment of prostate cancer
03/07/2002US20020028771 Sulfonylation core antibiotic
03/07/2002US20020028770 Bactericides
03/05/2002US6352824 Redox reversible bipyridyl-osmium complex conjugates
02/2002
02/27/2002EP1182210A1 Epitopes of tumor-associated MUC1 antigen
02/21/2002US20020022590 Useful as antibiotics; reduced tissue accumulation and/or nephrotoxicity when administered to a mammal; useful against vancomycin-resistant microorganisms
02/19/2002US6348567 A peptide derived from streptokinase; therapy for nervous system disorders, cardiovascular diseases, autoimmune diseases, parkinson's/alzheimer's/huntington's diseases and inflammatory diseases
02/14/2002WO2001058933A3 Selective n-acylation of a82846 glycopeptide analogs
02/13/2002EP1179011A1 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same
02/13/2002EP0866878A4 Detection of mammary tumor virus-like sequences in human breast cancer
02/07/2002US20020016285 Antitumor and/or antileukemic effects
02/07/2002US20020015680 A compound, comprising: a targeting moiety and a chelator, wherein the targeting moiety is bound to the chelator, is a qinolone nonpeptide, and binds to a receptor that is upregulated during angiogenesis
02/05/2002US6344551 Contulakin-G, analogs thereof and uses therefor
01/2002
01/30/2002EP0819136B1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same
01/29/2002US6342480 Tumor-activated prodrug compounds and treatment
01/24/2002WO2002006310A1 Peptide fructose and complex thereof with binding protein
01/24/2002WO2002005838A1 Derivatives of laspartomycin and preparation and use thereof
01/24/2002WO2000053614A8 Method for producing glyco-conjugates of 20(s)-camptothecin
01/24/2002US20020010131 Reductive alkylation process
01/24/2002CA2450747A1 Derivatives of laspartomycin and preparation and use thereof
01/24/2002CA2450372A1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
01/23/2002EP1173454A1 Method for producing glyco-conjugates of 20(s)-camptothecin
01/23/2002EP1173193A1 Desleucyl glycopeptide antibiotics and methods of making same
01/15/2002US6339069 Administering formulation comprising pharmaceutically acceptable carrier; and, liposome comprising a bioactive agent and a lipid component, the lipid component comprising a peptide-lipid conjugate
01/10/2002WO2001030804A3 Salt form of a conjugate useful in the treatment of prostate cancer
01/03/2002WO2001070275A3 Polyglutamic acid-camptothecin conjugates and methods of preparation
12/2001
12/27/2001WO2001098328A2 Glycopeptide phosphonate derivatives
12/27/2001WO2001098327A2 Glycopeptide carboxy-saccharide derivatives
12/27/2001WO2001098294A2 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
12/27/2001CA2713965A1 Glycopeptide phosphonate derivatives
12/27/2001CA2413957A1 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
12/13/2001WO2001042262A3 Antithrombotic compound
12/12/2001EP1162206A2 Peptide nucleic acids
12/11/2001US6329498 Amino acid sequence; stable preparation for treatment of human immunodeficiency virus
12/05/2001EP1159293A1 Bacterial transglycosylases: assays for monitoring the activity using lipid ii substrate analogs and methods for discovering new antibiotics
12/05/2001EP0939765B1 Glycoconjugates of modified camptothecin derivatives (a- or b-ring linkage)
12/04/2001US6326199 Hybridization and rnace activation in a cell with oligonucleotides
12/04/2001CA2046880C Substituted alkylamide derivatives of teicoplanin
11/2001
11/28/2001EP1157030A1 Echinocandin/carbohydrate complexes
11/28/2001CN1075501C Camptothecin derivatives, prepn. method, intermediate and uses
11/22/2001WO2000041710A9 Glycopeptide antibiotics containing a desmethylvancosamine residue, combinatorial libraries of same and methods of producing same
11/14/2001EP0912604B1 Improved chemical process for preparing amide derivatives of antibiotic A 40926
11/08/2001WO2001083521A2 Reductive alkylation process on glycopeptides
11/08/2001WO2001083520A2 Polyacid glycopeptide derivatives
11/08/2001WO2001082971A2 Cyclodextrin containing glycopeptide antibiotic compositions
11/08/2001CA2726789A1 Cyclodextrin containing glycopeptide antibiotic compositions
11/01/2001WO2001081373A2 Glycopeptide antibacterial compounds and methods of using same
11/01/2001WO2001081372A2 Vancomycin analogs
10/2001
10/25/2001WO2001079268A2 A glycopeptide and preparation thereof
10/25/2001WO2001079267A2 A glycopeptide and preparation thereof
10/25/2001WO2001079242A2 Process for preparing lipid ii and derivatives thereof
10/25/2001CA2406953A1 A glycopeptide and preparation thereof
10/25/2001CA2406952A1 Process for preparing lipid ii
10/24/2001EP1147129A1 Saccharides linked to compounds that bind cell-surface peptides or proteins
10/24/2001EP1147118A1 Substituted alpha-linked disaccharides
10/24/2001EP1146887A1 Glycopeptide antibiotics containing a desmethylvancosamine residue, combinatorial libraries of same and methods of producing same
10/23/2001CA2048407C Gonadoliberin antagonists
10/16/2001US6303120 Inducing antibodies in a subject to an allyl-substituted pentasaccharide by administering the compound conjugated to a protein carrier at its allyl group.
10/10/2001EP1140993A1 Glycopeptide derivatives and pharmaceutical compositions containing the same
10/10/2001EP1140864A2 Vitronectin receptor antagonist pharmaceuticals
10/04/2001EP1137812A1 Dna-protein fusions and uses thereof
10/03/2001CN1315961A Glycopeptide derivatives and pharmaceutical compositions containing same
10/02/2001CA2210987C Chromatographic purification of vancomycin hydrochloride by the use of preparative hplc
09/2001
09/27/2001WO2001070275A2 Polyglutamic acid-camptothecin conjugates and methods of preparation
09/27/2001CA2402643A1 Polyglutamic acid-camptothecin conjugates and methods of preparation
09/26/2001CN1314913A Directed combinatorial compound library and high throughput assays for screening same
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 34